We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cboe Global (CBOE) Stock Up 6% YTD: Will the Rally Continue?
Read MoreHide Full Article
Cboe Global Market’s (CBOE - Free Report) shares have gained 5.6% year to date, outperforming the industry’s increase of 4.3%. The Finance sector has declined 1.5% in the said time frame. With a market capitalization of $14 billion, the average volume of shares traded in the last three months was about 0.7 million.
Strong market position, global reach, strength in its proprietary products and solid capital position continue to drive this Zacks Rank #3 (Hold) securities and exchange company.
It is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. CBOE has a decent history of delivering earnings surprises in three of the last four reported quarters. Its earnings grew 13.7% in the last five years, better than the industry average of 10.5%.
Cboe Global’s ROE for the trailing 12 months was 22.3%, better than the industry average of 10.8%. It has a VGM Score of B. The VGM Score rates stocks on their combined weighted styles, helping to identify those with the most attractive value, best growth, and most promising momentum.
Image Source: Zacks Investment Research
Can It Retain the Bull Run?
The Zacks Consensus Estimate for Cboe Global’s 2023 earnings is pegged at $7.18, indicating a 3.6% increase from the year-ago reported figure on 8.3% higher revenues of $1.9 billion. The consensus estimate for 2024 is pegged at $7.43, indicating a year-over-year improvement of 3.6% on 3.5% higher revenues of $2 billion. It has a Growth Score of A. The Growth Style Score analyzes the growth prospects of a company.
Its wide geographic reach to the highest-value markets, a diversified business mix with recurring revenues, ramp-up of growth with recurring non-transaction revenues and technology leverage should continue to boost operational performance and fuel the top line. For the mid-to-long term, CBOE estimates organic top-line compound average growth of 4% to 6%.
Organic growth remained a key strength at Cboe Global Markets, as reflected in its revenue growth story. A volatile market continues to aid trading volume. CBOE estimates organic total net revenue growth between 7% and 9% in 2023.
Cboe Global Markets has an impressive inorganic growth story. The Bats Global buyout expanded and diversified its portfolio. MATCHNow helped it venture into Canada. BIDS Trading provided a meaningful presence in the substantial off-exchange segment of the U.S. equities market, while Chi-X Asia Pacific Holdings expanded its global equities business into the Asia Pacific region. The acquisition of ErisX enables Cboe to enter the digital asset spot and derivatives marketplaces through a digital-first platform, developed with industry partners to focus on robust regulatory compliance, data and transparency.
Cboe Global Markets expects acquisitions held less than a year to add around 0.5% to total net revenue growth in 2023.
Banking on operational excellence, CBOE increased dividends for 12 straight years as well as pursued share buybacks. As of Mar 31, 2023, CBOE had $147.9 million left under its current share repurchase authorization.
The Zacks Consensus Estimate for 2023 and 2024 has moved 0.3% and 0.4% north, respectively in the past 30 days, reflecting analyst optimism.
Kinsale delivered a four-quarter average earnings surprise of 14.77%. Year to date, the insurer has gained 23.8%.
The Zacks Consensus Estimate for KNSL’s 2023 and 2024 earnings indicates respective year-over-year increases of 32.9% and 19.7%. The company flaunts a Zacks Rank #1 at present.
CME delivered a four-quarter average earnings surprise of 2.20%. Year to date, the insurer has gained 5.1%.
The Zacks Consensus Estimate for CME’s 2023 and 2024 earnings indicates a year-over-year increase of 9.5% and 1.5%, respectively. It currently carries a Zacks Rank #2 (Buy).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cboe Global (CBOE) Stock Up 6% YTD: Will the Rally Continue?
Cboe Global Market’s (CBOE - Free Report) shares have gained 5.6% year to date, outperforming the industry’s increase of 4.3%. The Finance sector has declined 1.5% in the said time frame. With a market capitalization of $14 billion, the average volume of shares traded in the last three months was about 0.7 million.
Strong market position, global reach, strength in its proprietary products and solid capital position continue to drive this Zacks Rank #3 (Hold) securities and exchange company.
It is one of the largest stock exchange operators by volume in the United States and a leading market globally for ETP trading. CBOE has a decent history of delivering earnings surprises in three of the last four reported quarters. Its earnings grew 13.7% in the last five years, better than the industry average of 10.5%.
Cboe Global’s ROE for the trailing 12 months was 22.3%, better than the industry average of 10.8%. It has a VGM Score of B. The VGM Score rates stocks on their combined weighted styles, helping to identify those with the most attractive value, best growth, and most promising momentum.
Image Source: Zacks Investment Research
Can It Retain the Bull Run?
The Zacks Consensus Estimate for Cboe Global’s 2023 earnings is pegged at $7.18, indicating a 3.6% increase from the year-ago reported figure on 8.3% higher revenues of $1.9 billion. The consensus estimate for 2024 is pegged at $7.43, indicating a year-over-year improvement of 3.6% on 3.5% higher revenues of $2 billion. It has a Growth Score of A. The Growth Style Score analyzes the growth prospects of a company.
Its wide geographic reach to the highest-value markets, a diversified business mix with recurring revenues, ramp-up of growth with recurring non-transaction revenues and technology leverage should continue to boost operational performance and fuel the top line. For the mid-to-long term, CBOE estimates organic top-line compound average growth of 4% to 6%.
Organic growth remained a key strength at Cboe Global Markets, as reflected in its revenue growth story. A volatile market continues to aid trading volume. CBOE estimates organic total net revenue growth between 7% and 9% in 2023.
Cboe Global Markets has an impressive inorganic growth story. The Bats Global buyout expanded and diversified its portfolio. MATCHNow helped it venture into Canada. BIDS Trading provided a meaningful presence in the substantial off-exchange segment of the U.S. equities market, while Chi-X Asia Pacific Holdings expanded its global equities business into the Asia Pacific region. The acquisition of ErisX enables Cboe to enter the digital asset spot and derivatives marketplaces through a digital-first platform, developed with industry partners to focus on robust regulatory compliance, data and transparency.
Cboe Global Markets expects acquisitions held less than a year to add around 0.5% to total net revenue growth in 2023.
Banking on operational excellence, CBOE increased dividends for 12 straight years as well as pursued share buybacks. As of Mar 31, 2023, CBOE had $147.9 million left under its current share repurchase authorization.
The Zacks Consensus Estimate for 2023 and 2024 has moved 0.3% and 0.4% north, respectively in the past 30 days, reflecting analyst optimism.
Stocks to Consider
Some better-ranked stocks from the finance sector are RLI Corporation (RLI - Free Report) , Kinsale Capital Group (KNSL - Free Report) and CME Group (CME - Free Report) .
RLI delivered a four-quarter average earnings surprise of 43.50%. Year to date, the insurer has lost 1.8%.
The Zacks Consensus Estimate for RLI’s 2023 earnings indicates a year-over-year increase of 4.1%. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Kinsale delivered a four-quarter average earnings surprise of 14.77%. Year to date, the insurer has gained 23.8%.
The Zacks Consensus Estimate for KNSL’s 2023 and 2024 earnings indicates respective year-over-year increases of 32.9% and 19.7%. The company flaunts a Zacks Rank #1 at present.
CME delivered a four-quarter average earnings surprise of 2.20%. Year to date, the insurer has gained 5.1%.
The Zacks Consensus Estimate for CME’s 2023 and 2024 earnings indicates a year-over-year increase of 9.5% and 1.5%, respectively. It currently carries a Zacks Rank #2 (Buy).